SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (8927)6/2/1998 8:03:00 PM
From: VLAD  Read Replies (1) | Respond to of 23519
 
DaiS,

Many pharmacies do not even carry MUSE and those that do do not carry large stocks of MUSE.

Think about it DaiS, According to IMS data MUSE was selling about 15,000 scripts before Viagra came on the market. Now if you look at the number of pharmacies in the United States (I don't know the number but I think it is much greater than 15,000) it probably equates to less than one 6 pack of MUSE per pharmacy.

Therfore there will be no reason to see returns. The wholesalers will simply not order as much MUSE from Vivus and the extra product can be diverted to Europe.



To: DaiS who wrote (8927)6/2/1998 9:50:00 PM
From: Don Dunlap  Read Replies (2) | Respond to of 23519
 
Dais, <<And presumably they cannot be returned to Vivus and
shipped to UK - or can they.>>

Sales are booked as revenue when the product is shipped, and yes, unsold product can be returned. This is potentially a huge liability. I don't know what the expiration period is on the product.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News